Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0001193125-26-412655

Options or other derivatives

  • Director acquired 1,325 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

PAPA JOSEPH C · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-30 Grant or award : show line 1 in the form Stock Option (Right to Buy) +1,325 $8.68 $11,496 1,325 D
Loading xslF345X06/ownership.xml…